Skip to main content
. 2020 Mar 25;14:208. doi: 10.3389/fnins.2020.00208

TABLE 3.

Scores of adverse reactions.

iTBS-L-D (n = 26) cTBS-L-D(n = 18) cTBS-R-D (n = 30) ANOVA P value Posthoc (FDR correcteda)
Headache 1.88 (3.49) 3.67 (5.35) 0.57 (2.0) F = 4.23 0.02 cTBS-L > iTBS-L
cTBS-L > cTBS-R
Neck pain 0 (0) 0.11 (0.47) 0 (0) F = 1.58 0.21 NA
Scalp pain 0.92 (3.30) 2.38 (4.50) 0.17 (0.53) F = 3.16 0.05 cTBS-L > iTBS-L
cTBS-L > cTBS-R
Tingling 5.35 (7.10) 5.06 (5.98) 3.90 (7.32) F = 0.34 0.72 NA
Itching 0 (0) 0.11 (0.47) 0 (0) F = 1.59 0.21 NA
Burning Sensation 0 (0) 0.27 (0.83) 0 (0) F = 3.21 0.05 NA
Sleepiness 11.61 (18.23) 1.28 (2.49) 6.80 (15.14) F = 2.69 0.08 NA
Trouble 0 (0) 1.44 (2.15) 0.233 (1.28) F = 6.91 0.002
Concentrating cTBS-L > iTBS-L
cTBS-L > cTBS-R
Mood Change 0.31 (1.57) 2.44 (4.68) 0.17 (0.91) F = 5.19 0.008 cTBS-L > iTBS-L
cTBS-L > cTBS-R

Data are presented as mean (SD). aMultiple comparisons were corrected by the false discovery rate (FDR) correction.